These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 16563590)
61. Allosteric modulation of the effects of the 5-HT reuptake inhibitor escitalopram on the rat hippocampal synaptic plasticity. Mnie-Filali O; El Mansari M; Espana A; Sànchez C; Haddjeri N Neurosci Lett; 2006 Feb; 395(1):23-7. PubMed ID: 16330146 [TBL] [Abstract][Full Text] [Related]
62. Sex differences in the ACTH and cortisol response to pharmacological probes are stressor-specific and occur regardless of alcohol dependence history. Anthenelli RM; Heffner JL; Blom TJ; Daniel BE; McKenna BS; Wand GS Psychoneuroendocrinology; 2018 Aug; 94():72-82. PubMed ID: 29763783 [TBL] [Abstract][Full Text] [Related]
63. Neuroendocrine effects of intravenous clomipramine in depressed patients and healthy subjects. Golden RN; Ekstrom D; Brown TM; Ruegg R; Evans DL; Haggerty JJ; Garbutt JC; Pedersen CA; Mason GA; Browne J Am J Psychiatry; 1992 Sep; 149(9):1168-75. PubMed ID: 1323933 [TBL] [Abstract][Full Text] [Related]
65. Lack of clinically significant interactions between concomitantly administered rasagiline and escitalopram. Hilli J; Korhonen T; Laine K Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1526-32. PubMed ID: 19733607 [TBL] [Abstract][Full Text] [Related]
66. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial. Stahl SM; Gergel I; Li D J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946 [TBL] [Abstract][Full Text] [Related]
67. Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain. Ortega JE; Gonzalez-Lira V; Horrillo I; Herrera-Marschitz M; Callado LF; Meana JJ Eur J Pharmacol; 2013 Jun; 709(1-3):13-9. PubMed ID: 23562616 [TBL] [Abstract][Full Text] [Related]
68. Blunted 5-HT1A-receptor agonist-induced corticotropin and cortisol responses after long-term ipsapirone and fluoxetine administration to healthy subjects. Berlin I; Warot D; Legout V; Guillemant S; Schöllnhammer G; Puech AJ Clin Pharmacol Ther; 1998 Apr; 63(4):428-36. PubMed ID: 9585797 [TBL] [Abstract][Full Text] [Related]
69. Neuroendocrine effects of quetiapine in healthy volunteers. de Borja Gonçalves Guerra A; Castel S; Benedito-Silva AA; Calil HM Int J Neuropsychopharmacol; 2005 Mar; 8(1):49-57. PubMed ID: 15469666 [TBL] [Abstract][Full Text] [Related]
70. Serotonergic modulation of response inhibition and re-engagement? Results of a study in healthy human volunteers. Drueke B; Boecker M; Schlaegel S; Moeller O; Hiemke C; Gründer G; Gauggel S Hum Psychopharmacol; 2010 Aug; 25(6):472-80. PubMed ID: 20737520 [TBL] [Abstract][Full Text] [Related]
71. Reboxetine and citalopram in panic disorder: a single-blind, cross-over, flexible-dose pilot study. Seedat S; van Rheede van Oudtshoorn E; Muller JE; Mohr N; Stein DJ Int Clin Psychopharmacol; 2003 Sep; 18(5):279-84. PubMed ID: 12920388 [TBL] [Abstract][Full Text] [Related]
72. Neuroendocrine evidence for reduced serotonergic neurotransmission during heavy drinking. Balldin J; Berggren U; Engel J; Eriksson M Alcohol Clin Exp Res; 1994 Aug; 18(4):822-5. PubMed ID: 7978090 [TBL] [Abstract][Full Text] [Related]
73. Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial. Pallanti S; Quercioli L; Koran LM J Clin Psychiatry; 2002 Sep; 63(9):796-801. PubMed ID: 12363120 [TBL] [Abstract][Full Text] [Related]
74. The clinical pharmacokinetics of escitalopram. Rao N Clin Pharmacokinet; 2007; 46(4):281-90. PubMed ID: 17375980 [TBL] [Abstract][Full Text] [Related]
75. Mirtazapine decreases stimulatory effects of reboxetine on cortisol, adrenocorticotropin and prolactin secretion in healthy male subjects. Schüle C; Baghai T; Laakmann G Neuroendocrinology; 2004 Jan; 79(1):54-62. PubMed ID: 14755134 [TBL] [Abstract][Full Text] [Related]
76. Effect of subchronic lithium treatment on citalopram-induced increases in extracellular concentrations of serotonin in the medial prefrontal cortex. Muraki I; Inoue T; Hashimoto S; Izumi T; Ito K; Koyama T J Neurochem; 2001 Jan; 76(2):490-7. PubMed ID: 11208912 [TBL] [Abstract][Full Text] [Related]
77. Neuroendocrine and hypothermic effects of 5-HT1A receptor stimulation with ipsapirone in healthy men: a placebo-controlled study. Cleare AJ; Forsling M; Bond AJ Int Clin Psychopharmacol; 1998 Jan; 13(1):23-32. PubMed ID: 9988364 [TBL] [Abstract][Full Text] [Related]
78. Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response. Nikisch G; Mathé AA; Czernik A; Thiele J; Bohner J; Eap CB; Agren H; Baumann P Psychopharmacology (Berl); 2005 Oct; 181(4):751-60. PubMed ID: 15988572 [TBL] [Abstract][Full Text] [Related]
79. Reboxetine acutely stimulates cortisol, ACTH, growth hormone and prolactin secretion in healthy male subjects. Schüle C; Baghai T; Schmidbauer S; Bidlingmaier M; Strasburger CJ; Laakmann G Psychoneuroendocrinology; 2004 Feb; 29(2):185-200. PubMed ID: 14604600 [TBL] [Abstract][Full Text] [Related]
80. Selective serotonin reuptake inhibitors and neuroendocrine function. Raap DK; Van de Kar LD Life Sci; 1999; 65(12):1217-35. PubMed ID: 10503938 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]